Loading...

Pump Users Clamor for Faster Insulin: Is Fast-Acting Insulin Aspart Ready for Them?

Recently approved in Europe, Canada, and the United States, fast-acting insulin aspart (FIASP®) is a new rapid acting insulin. Approved for subcutaneous or IV injection use, there is little data available regarding the clinical utility of FIASP in insulin pumps. The article by Zijlstra and colleague...

Full description

Saved in:
Bibliographic Details
Published in:J Diabetes Sci Technol
Main Author: Muchmore, Douglas B.
Format: Artigo
Language:Inglês
Published: SAGE Publications 2018
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5761999/
https://ncbi.nlm.nih.gov/pubmed/29291651
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1932296817750166
Tags: Add Tag
No Tags, Be the first to tag this record!